A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues

Bioorg Med Chem. 2006 Sep 15;14(18):6239-54. doi: 10.1016/j.bmc.2006.05.055. Epub 2006 Jun 16.

Abstract

Based on 1,2-O-isopropylidene-sn-glycerol five chiral building blocks containing differently modified glycerol residues were required for the synthesis of the target molecule 2. One of these building blocks is diacylglyceryl beta-gentiobioside carrying a phosphite residue at 6b-O position. Ligation of these five building blocks led to the desired glycerol phosphate backbone to which d-alanyl residues were attached, thus generating after O-deprotection the target molecule 2, a bisamphiphilic structural variant of Staphylococcus aureus LTA. This compound displayed higher potency in terms of cytokine release by human blood leukocytes than the monoamphiphilic variant LTA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbohydrate Conformation
  • Carbohydrate Sequence
  • Cytokines / biosynthesis
  • Cytokines / drug effects
  • Diglycerides / chemistry*
  • Dose-Response Relationship, Drug
  • Humans
  • Leukocytes / drug effects
  • Lipopolysaccharides / chemical synthesis
  • Lipopolysaccharides / chemistry*
  • Lipopolysaccharides / pharmacology
  • Molecular Conformation
  • Molecular Sequence Data
  • Staphylococcus aureus / chemistry*
  • Stereoisomerism
  • Structure-Activity Relationship
  • Teichoic Acids / chemical synthesis
  • Teichoic Acids / chemistry*
  • Teichoic Acids / pharmacology

Substances

  • Cytokines
  • Diglycerides
  • Lipopolysaccharides
  • Teichoic Acids
  • lipoteichoic acid